Whalegun
Lobbying

MT Pharma America's latest lobbying report covers Q3 2024, at $20K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.

MT Pharma America

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

MT Pharma America lobbying by quarter
MT Pharma America lobbying by quarter
QuarterAmountReports
Q4 2022$30K1
Q1 2023$30K1
Q2 2023$30K1
Q3 2023$30K1
Q4 2023$30K1
Q1 2024$30K1
Q2 2024$30K1
Q3 2024$20K1
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$110K · 8 reports
  • Medicare and Medicaid$110K · 8 reports
  • Medical research and clinical labs$10K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES8 reports
  • SENATE8 reports

Firms it paid

Firm
Williams and Jensen, PLLC$230K8 quarters

Former officials lobbying for it

Former position
KARINA LYNCHStaff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. AffairsQ3 2024
CHERYL LYNN JAEGERShd employee, Ofc of the Speaker 7 Ofc of VA 7; Sr. Policy Adv, Maj Leader, Rep Cantor; Sr. Policy Adv, Rep Whip, Rep Cantor; Sr. Policy Adv, Maj Whip, Rep Blunt; Prof Staff House Committee on E&C; Sr LA to Rep C. CoxQ1 2023

Lobbying reports

Filed by
24/10/04for Q3 2024Williams and Jensen, PLLC$20K
24/07/19for Q2 2024Williams and Jensen, PLLC$30K
24/04/18for Q1 2024Williams and Jensen, PLLC$30K
24/01/17for Q4 2023Williams and Jensen, PLLC$30K
23/10/17for Q3 2023Williams and Jensen, PLLC$30K
23/07/14for Q2 2023Williams and Jensen, PLLC$30K
23/04/19for Q1 2023Williams and Jensen, PLLC$30K
23/01/20for Q4 2022Williams and Jensen, PLLC$30K